|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5310 EUR | -4.84% |
|
-14.08% | -65.43% |
| 13/07 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 10/07 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.84% | -14.08% | -38.82% | -54.46% | -65.43% | -57.32% | -87.19% | -96.53% | -96.20% | 5.1Cr | |
| +2.53% | +2.32% | +9.19% | +13.93% | +24.06% | +55.50% | +20.04% | +68.42% | +123.00% | 31TCr | |
| +2.12% | +0.94% | +3.15% | +24.27% | +13.58% | +24.00% | -11.62% | -19.95% | +43.63% | 6.79TCr | |
| +1.46% | +2.31% | +13.95% | +19.13% | +17.88% | +35.47% | +85.52% | +84.96% | +753.93% | 923.05Cr | |
| -1.26% | -1.72% | +2.57% | +8.49% | +2.65% | +4.64% | -3.98% | -30.36% | +36.31% | 843.12Cr | |
| +3.78% | +1.92% | -6.78% | -23.00% | -36.04% | -21.25% | -6.67% | -35.73% | - | 407.28Cr | |
| +0.07% | -9.52% | +3.76% | +37.54% | +30.11% | -5.52% | +22.21% | -34.68% | - | 377.19Cr | |
| +1.71% | +2.73% | -2.72% | -24.92% | -36.48% | -42.88% | +11.90% | +34.40% | +72.93% | 354.49Cr | |
| +0.64% | -2.39% | +5.80% | -6.61% | -5.31% | +42.74% | +56.61% | +72.57% | +118.88% | 272.44Cr | |
| -0.30% | -6.60% | +8.74% | -14.76% | -16.87% | +4.82% | -10.21% | +44.86% | - | 213.28Cr | |
| +2.66% | -6.39% | +18.24% | -4.09% | +1.81% | -18.43% | +36.47% | -29.33% | - | 194.59Cr | |
| +0.57% | -3.63% | +5.93% | -10.25% | -13.27% | -21.58% | -17.67% | -10.61% | -43.08% | 173.49Cr | |
| -.--% | -.--% | - | - | - | - | - | - | - | 164.41Cr | |
| -0.05% | -8.11% | -1.87% | -26.25% | -15.13% | -36.56% | -30.60% | - | - | 120.64Cr | |
| +1.68% | +18.85% | +31.98% | +92.42% | +161.38% | +189.08% | +1,408.53% | +690.70% | - | 119.38Cr | |
| +2.92% | -4.00% | -12.29% | -41.53% | -41.40% | +34.52% | +26.32% | +14.87% | +425.37% | 106.32Cr | |
| +0.83% | -18.71% | +12.79% | +4.85% | +13.85% | -13.84% | +91.88% | +6.98% | - | 113.67Cr | |
| +0.72% | +1.20% | +7.11% | -7.66% | -9.25% | +2.06% | +42.52% | +85.99% | +79.96% | 106.48Cr | |
| -1.30% | -5.70% | +0.77% | -20.81% | -23.75% | -36.54% | -75.64% | -84.79% | - | 88Cr | |
| +0.83% | -2.81% | +3.86% | -13.57% | -12.95% | -43.33% | -11.36% | -50.00% | -65.92% | 87Cr | |
| Average | +0.72% | -1.69% | +3.44% | -2.49% | -0.55% | +5.03% | +81.42% | +39.54% | +131.71% | 2.15TCr | |
| Weighted average by Cap. | +2.28% | +3.02% | +7.86% | +14.42% | +20.00% | +45.34% | +19.37% | +50.62% | +121.36% |
- Stock Market
- Stocks
- AB Stock
- Sector AB Science
Select your edition
All financial news and data tailored to specific country editions
